Status:
COMPLETED
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
Brief Summary
The purpose of this study is to collect and compare information regarding the treatment and outcome of patients diagnosed with Alzheimer's disease who are receiving either drug or nondrug treatment. I...
Detailed Description
Dementia is a chronic, progressive brain disease that may involve a number of symptoms, including memory loss and changes in personality, behavior, judgment, attention span, language and thought. The ...
Eligibility Criteria
Inclusion
- Patients diagnosed with new or previous mild or moderate Alzheimer's disease diagnosed by a doctor according to medically-accepted definitions
- Patients living in ordinary households (for example in their own home or in the home of a family member or friend, not in nursing homes or other long-term care facilities)
Exclusion
- Patients who are currently participating in another clinical trial
Key Trial Info
Start Date :
July 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
2360 Patients enrolled
Trial Details
Trial ID
NCT00291421
Start Date
July 1 2002
End Date
May 1 2006
Last Update
April 16 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.